We are live on ! Find out more
Ameriprise

Ameriprise Portfolio holdings

AUM $432B
1-Year Est. Return 30.22%
 

Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.

This Fund
S&P 500
This Quarter Est. Return
-13.14%
1 Year Est. Return
+30.22%
3 Year Est. Return
+89.37%
5 Year Est. Return
+112.58%
10 Year Est. Return
+510.85%
AUM
$200B
AUM Growth
-$86.1B
Cap. Flow
-$3.48B
Cap. Flow %
-1.74%
Top 10 Hldgs %
13.98%
Holding
3,899
New
170
Increased
1,630
Reduced
1,715
Closed
248

Sector Composition

Rank Sector Weight
1 Technology 17%
2 Financials 12.96%
3 Healthcare 12.18%
4 Consumer Discretionary 8.39%
5 Industrials 7.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMRX icon
926
Amneal Pharmaceuticals
AMRX
$5.71B
$25.1M 0.01%
1,857,669
-81,430
-4% -$1.47M
VOD icon
927
Vodafone
VOD
$36.4B
$25.1M 0.01%
1,302,441
+272,817
+26% +$5.45M
FOXF icon
928
Fox Factory Holding Corp
FOXF
$882M
$25.1M 0.01%
426,949
+20,289
+5% +$1.26M
KEYS icon
929
Keysight
KEYS
$57.3B
$25.1M 0.01%
404,426
-256,054
-39% -$15.4M
ARCE
930
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
$25M 0.01%
1,129,820
+384,823
+52% +$8.51M
RWL icon
931
Invesco S&P 500 Revenue ETF
RWL
$9.95B
$25M 0.01%
482,760
-412,225
-46% -$20.9M
LUMN icon
932
Lumen
LUMN
$6.85B
$24.8M 0.01%
1,616,287
-42,301
-3% -$807K
RNST icon
933
Renasant Corp
RNST
$3.9B
$24.8M 0.01%
819,733
-120,737
-13% -$4.23M
ABCB icon
934
Ameris Bancorp
ABCB
$5.88B
$24.7M 0.01%
780,082
-30,828
-4% -$1.26M
TTMI icon
935
TTM Technologies
TTMI
$13.7B
$24.7M 0.01%
2,536,126
+17,557
+0.7% +$215K
HOLX
936
DELISTED
Hologic
HOLX
$24.6M 0.01%
598,893
-213,264
-26% -$8.75M
SIGI icon
937
Selective Insurance
SIGI
$5.66B
$24.6M 0.01%
403,220
+40,052
+11% +$2.49M
EVH icon
938
Evolent Health
EVH
$444M
$24.5M 0.01%
1,229,258
-537,462
-30% -$12.4M
HEWG
939
DELISTED
iShares Currency Hedged MSCI Germany ETF
HEWG
$24.5M 0.01%
1,030,368
-499,146
-33% -$12.6M
AMLP icon
940
Alerian MLP ETF
AMLP
$13.3B
$24.5M 0.01%
564,687
-41,603
-7% -$2.04M
SR icon
941
Spire
SR
$4.79B
$24.4M 0.01%
329,777
-2,829
-0.9% -$214K
NAV
942
DELISTED
Navistar International
NAV
$24.4M 0.01%
939,751
+36,560
+4% +$1.14M
LPT
943
DELISTED
Liberty Property Trust
LPT
$24.2M 0.01%
578,840
-6,443
-1% -$278K
FBT icon
944
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.81B
$24.2M 0.01%
194,224
+2,533
+1% +$346K
SIG icon
945
Signet Jewelers
SIG
$3.67B
$24.2M 0.01%
761,274
+66,722
+10% +$3.35M
TDOC icon
946
Teladoc Health
TDOC
$1.29B
$24.2M 0.01%
488,554
+180,012
+58% +$11M
SAGE
947
DELISTED
Sage Therapeutics
SAGE
$24.1M 0.01%
251,754
-78,083
-24% -$8.94M
ATR icon
948
AptarGroup
ATR
$8.5B
$24.1M 0.01%
255,866
-96,829
-27% -$9.87M
MMS icon
949
Maximus
MMS
$2.9B
$24.1M 0.01%
369,481
-23,388
-6% -$1.54M
KAMN
950
DELISTED
Kaman Corp
KAMN
$24M 0.01%
428,085
+105,800
+33% +$6.26M

Similar funds

Ameriprise's Q4 2018 Portfolio in Review

As of Q4 2018, Ameriprise held 3,899 positions worth $200B, down 30% from $286B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Ameriprise's Q4 2018 filing shows 170 new, 1,630 increased, 1,715 reduced and 248 closed positions. Its largest new stake was Linde: 460,065 shares worth $71.8M. The largest sale was Express Scripts Holding Company, an estimated $475M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Ameriprise's largest Q4 2018 buy was Linde: 460,065 shares worth $71.8M.
  • Ameriprise added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q4 2018, an estimated $760M increase.
  • Ameriprise's biggest Q4 2018 reduction was Pfizer, cutting an estimated $356M.
  • Ameriprise fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $475M.
  • Ameriprise's ten largest holdings make up 14% of its $200B portfolio in Q4 2018.
  • Ameriprise opened 170 new positions and closed 248 in Q4 2018.
  • Ameriprise's portfolio value fell 30% quarter-over-quarter to $200B.

Based on Ameriprise's 13F filing for Q4 2018, filed 14 Feb 2019.